Target Information
| Target General Information | Top | |||||
|---|---|---|---|---|---|---|
| Target ID |
T93430
(Former ID: TTDI01708)
|
|||||
| Target Name |
ATP-binding cassette transporter (ABCA)
|
|||||
| Gene Name |
NO-GeName
|
|||||
| Target Type |
Clinical trial target
|
[1] | ||||
| Disease | [+] 1 Target-related Diseases | + | ||||
| 1 | Insulin-resistance syndrome [ICD-11: 5A44] | |||||
| BioChemical Class |
ABC transporter
|
|||||
| UniProt ID | ||||||
| Drugs and Modes of Action | Top | |||||
|---|---|---|---|---|---|---|
| Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
| 1 | LIM-0705 | Drug Info | Phase 2 | Insulin-resistant disorder | [2] | |
| Mode of Action | [+] 1 Modes of Action | + | ||||
| Activator | [+] 1 Activator drugs | + | ||||
| 1 | LIM-0705 | Drug Info | [1] | |||
| References | Top | |||||
|---|---|---|---|---|---|---|
| REF 1 | WO patent application no. 2010,0428,86, Pyrone analogs for therapeutic treatment. | |||||
| REF 2 | ClinicalTrials.gov (NCT01364155) Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR. U.S. National Institutes of Health. | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.